Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    ... Diagnosis of acute myelogenous leukemia , chronic myelogenous leukemia, other myeloproliferative disorder, or ... <70% Life expectancy limited by another co-morbid illness Diagnosed or treated for another malignancy within 3 years of ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  2. Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

    ... Life expectancy is not severely limited by concomitant illness Adequate cardiac and pulmonary function; patients with decreased ... on protocol after discussion with the PI No evidence of chronic active hepatitis or cirrhosis Human immunodeficiency virus ...

    Clinical Trial last updated 05/23/2016 - 2:06pm.

  3. Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia

    ... blasts in the bone marrow ) or patients with Chronic Myelomonocytic Leukemia (CMML) (having >/= 10% blasts in the bone ... medical condition, laboratory abnormality, or psychiatric illness, which could place him/her at unacceptable risk. Patients who have ...

    Clinical Trial last updated 05/23/2016 - 3:37pm.

  4. Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic

    ... leukemia (ALL) in 1st or subsequent remission Chronic myelogenous leukemia (CML) in chronic or accelerated phase ... Pregnant or breastfeeding. Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic ...

    Clinical Trial last updated 04/29/2016 - 4:33pm.

  5. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... with bone marrow (BM) as a stem cell source. Although chronic graft versus host disease (cGVHD) occurs less commonly with BM compared ... Recipient: any of the following Major anticipated illness or organ failure incompatible with survival from PBSC transplant ...

    Clinical Trial last updated 04/28/2016 - 2:40pm.

  6. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... Exclusion Criteria:  Evidence of chronic active hepatitis or cirrhosis HIV infection Uncontrolled illness including, but not limited to, ongoing or active infection, symptomatic ...

    Clinical Trial last updated 05/02/2016 - 11:10am.

  7. Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

    ... of neutrophils and platelets, low incidences of acute and chronic graft versus host disease, low frequency of delayed opportunistic ... 3.1.1 Life expectancy is severely limited by concomitant illness or uncontrolled infection Subjects with severely decreased Left ...

    Clinical Trial last updated 04/29/2016 - 1:15pm.

  8. Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

    ... of multiple myeloma or extramedullary plasmacytoma Chronic disease or co-morbid medical condition including subjects with symptoms ... and making informed consent impossible Major anticipated illness or organ failure incompatible with survival from PBSC transplant ...

    Clinical Trial last updated 04/28/2016 - 2:08pm.

  9. Build a Support Team

    ... forums offers the level of support they need. Having a chronic disease can be very difficult. Knowing that someone is in your corner ... to care, medical debt and job retention related to their illness. Their services may be free. To learn more, call them at (800) ...

    Page last updated 05/02/2016 - 11:56am.

  10. Safety and Effect of GL-ONC1 Administered IV With or Without Eculizumab Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery

    ... to receive study treatment (i.e. uncontrolled diabetes, chronic renal disease, chronic pulmonary disease or active, fever, systemic and/or uncontrolled infections, psychiatric illness/social situations that would limit compliance with study requirements). ...

    Clinical Trial last updated 04/28/2016 - 1:57pm.